# Andrew M. Scott

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrew-m-scott/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,284 |
| Field | Radiopharmaceutical Chemistry and Applications |
| h-index | 95 |
| i10-index | 491 |
| Last Known Institution | La Trobe University |
| OpenAlex ID | https://openalex.org/A5078312966 |
| ORCID iD | https://orcid.org/0000-0002-6656-295X |
| Works | 1,196 |

## Researcher papers

- [\[177Lu\]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial](https://scholariq.org/papers/177lu-lu-psma-617-versus-cabazitaxel-in-patients-with-metastatic-castration/)
- [Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans](https://scholariq.org/papers/recombinant-ny-eso-1-protein-with-iscomatrix-adjuvant-induces-broad-integrated/)
- [Radiotheranostics in oncology: current challenges and emerging opportunities](https://scholariq.org/papers/radiotheranostics-in-oncology-current-challenges-and-emerging-opportunities/)
- [Bridging Bio–Nano Science and Cancer Nanomedicine](https://scholariq.org/papers/bridging-bio-nano-science-and-cancer-nanomedicine/)
- [PSMA and FDG-PET as predictive and prognostic biomarkers in patients given \[177Lu\]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial](https://scholariq.org/papers/psma-and-fdg-pet-as-predictive-and-prognostic-biomarkers-in-patients-given-177lu/)
- [Overall survival with \[177Lu\]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial](https://scholariq.org/papers/overall-survival-with-177lu-lu-psma-617-versus-cabazitaxel-in-metastatic/)

## Researcher topics

- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Medical Imaging Techniques and Applications](https://scholariq.org/topics/medical-imaging-techniques-and-applications/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [La Trobe University](https://scholariq.org/institutions/la-trobe-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.